Tisotumab vedotin Antibody
Tisotumab vedotin is an antibody-drug conjugate (ADC) targeting tissue factor (TF) and delivering the cytotoxic payload MMAE. It demonstrates potent antitumor activity in preclinical models and is clinically investigated for treating advanced solid tumors, including cervical and ovarian cancers.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs)
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
6.14 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog